Page 28 - Caredx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. ...

False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. ...

Page 260 of 260: O fato de treino é lindo lindo fdx. ❤️🤍#129293💪#128170

Partnership with OrganX to develop decision support systemsSOUTH SAN FRANCISCO, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has entered into a strategic agreement with OrganX to develop clinical decision support tools across the transplant patient journe

Study to demonstrate utility of LiverCare post-transplant surveillance for liver transplant recipientsSOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the enrollment of the first patient in the Molecular Assessment and Profiling of Liver Transplant Recipients (MAPLE) Study at Mount Sinai Hospital in New York. MAPLE is a multi-center, prosp...